Medical-Device Makers Face Hurdles Despite Tax Repeal
U.S. lawmakers’ elimination of the 2.3% excise tax on medical devices in 2020 will remove some uncertainty for the industry, but bottom lines and broader challenges may remain static. Payers continue to cut reimbursements and more money is going to share buybacks and dividends than to R&D.